Norton Rose Fulbright supports launch of Law Beats Cancer initiative with Cancer Research UK

Norton Rose Fulbright is proud to support the launch of Law Beats Cancer, a new initiative between the legal community and Cancer Research UK.

Law Beats Cancer has been established to mobilise the whole profession - including solicitors, barristers, in-house teams and suppliers to the legal sector - around a shared cause to accelerate life-saving cancer research. The initiative focuses on coordinated fundraising, networking, awareness, wellbeing and pro bono initiatives that will drive progress to save and improve more lives.

Law Beats Cancer has launched with strong backing from across the legal sector.

Duncan Batchelor, partner at Norton Rose Fulbright and Chair of the Law Beats Cancer Board, commented:

"Cancer Research UK's progress against cancer depends on sustained investment in research, made possible by its supporters. The legal profession, meanwhile, has extraordinary networks and influence. Law Beats Cancer was created to bring those two forces together.

"Nothing like this has been done before, linking solicitors, barristers and in-house teams. We aim to extend it to law students and others too, making the most of the power of our networks. It is more than a campaign, it is a movement and the potential is huge.

"Law Beats Cancer does not belong to any one firm; it belongs to the entire profession, giving us an opportunity to come together as a community and do something special, as a force for good. We are delighted with the support and enthusiasm from everyone so far. We already have so many firms and institutions who have signed up as supporters and we would welcome more. This is just the beginning."

Claudia Nicholls, Cancer Research UK's Executive Director of Marketing, Fundraising and Engagement, said:

"Law Beats Cancer is a brilliant example of what happens when a profession decides to put its collective weight behind something that matters. The legal community has real power to make a difference, and seeing that power directed towards life-saving cancer research is genuinely exciting. Every pound raised makes a difference for people affected by cancer and their loved ones."

Law firms, chambers, in-house teams and individuals can register their interest, learn more or donate at www.lawbeatscancer.org.

Notes to editors

1. The founding Board of Law Beats Cancer is made up of Duncan Batchelor, Partner at Norton Rose Fulbright; Jenny Leahy, Partner at Freshfields; Andrew Richards, Chief Finance Officer at CMS; Paul Baker, Partner at Quinn Emanuel; Charlotte Eberlein, Head of Marketing & BD at Thomson Snell & Passmore; Akhil Shah KC; Sarah Clements, Group General Counsel at International Airline Group; and Mary Mullally, Director at Executive Peer Networks.
2. Initial supporter firms include BCLP, Cleary Gottlieb, CMS, Dentons, Freshfields, Geldards, Higgs, Lewis Silkin, Linklaters, Norton Rose Fulbright, RPC, Quinn Emanuel, Simmons & Simmons, Taylor Emmet and Thomson Snell & Passmore, as well as Harvey AI. Others are in the process of joining.
3. About Cancer Research UK

• Cancer Research UK is the world's leading cancer charity dedicated to saving and improving lives through research, influence and information.
• Cancer Research UK's pioneering work into the prevention, detection and treatment of cancer has helped save millions of lives.
• Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double over the past 50 years.
• Cancer Research UK supports research into the prevention and treatment of cancer through the work of over 4,000 scientists, doctors and nurses.
• Together with its partners and supporters, Cancer Research UK is working towards a world where everybody can live longer, better lives, free from the fear of cancer.
• For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit https://www.cruk.org

1. Over the past 50 years, Cancer Research UK's work has helped double cancer survival in the UK. But with nearly one in two people in the UK set to be diagnosed with cancer during their lifetime*, the urgency for continued investment in research has never been greater. Cancer Research UK is committed to funding as much world-class research as possible but relies on the generosity of its supporters and partners to continue its pioneering work. *https://www.cruk.org/lifetimerisk